MLICM
INVX

Metropolitan Life Insurance Company (MetLife)’s Innovex International INVX Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio INVX Stock Details INVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,047
Closed -$46.1K – 2182
2024
Q1 		$46.1K Hold
2,047
– – ﹤0.01% 1445
2023
Q4 		$47.6K Hold
2,047
– – ﹤0.01% 1474
2023
Q3 		$57.7K Buy
2,047
+264
+15% +$7.17K ﹤0.01% 1323
2023
Q2 		$41.5K Hold
1,783
– – ﹤0.01% 1532
2023
Q1 		$51.2K Sell
1,783
-228
-11% -$6.76K ﹤0.01% 1379
2022
Q4 		$54.6K Hold
2,011
– – ﹤0.01% 1419
2022
Q3 		$39.3K Hold
2,011
– – ﹤0.01% 1617
2022
Q2 		$51.9K Hold
2,011
– – ﹤0.01% 1486
2022
Q1 		$75.1K Sell
2,011
-7,260
-78% -$208K ﹤0.01% 1376
2021
Q4 		$182K Hold
9,271
– – ﹤0.01% 2089
2021
Q3 		$233K Hold
9,271
– – ﹤0.01% 1953
2021
Q2 		$314K Sell
9,271
-1,423
-13% -$47.9K ﹤0.01% 1828
2021
Q1 		$355K Sell
10,694
-470
-4% -$16.1K 0.01% 1632
2020
Q4 		$331K Hold
11,164
– – ﹤0.01% 1626
2020
Q3 		$276K Hold
11,164
– – ﹤0.01% 1590
2020
Q2 		$333K Sell
11,164
-343
-3% -$10.5K 0.01% 1484
2020
Q1 		$351K Buy
11,507
+367
+3% +$14.3K 0.01% 1261
2019
Q4 		$523K Sell
11,140
-298
-3% -$13.6K 0.01% 1296
2019
Q3 		$574K Sell
11,438
-974
-8% -$47.5K 0.01% 1201
2019
Q2 		$596K Hold
12,412
– – 0.01% 1192
2019
Q1 		$569K Sell
12,412
-9,362
-43% -$368K 0.01% 1219
2018
Q4 		$654K Sell
21,774
-437
-2% -$17.6K 0.01% 1046
2018
Q3 		$1.16M Sell
22,211
-175
-0.8% -$9.13K 0.02% 853
2018
Q2 		$1.15M Buy
22,386
+1,037
+5% +$48.3K 0.02% 851
2018
Q1 		$956K Sell
21,349
-890
-4% -$43.5K 0.01% 922
2017
Q4 		$1.06M Sell
22,239
-38,504
-63% -$1.72M 0.01% 862
2017
Q3 		$2.68M Sell
60,743
-117
-0.2% -$5.09K 0.02% 848
2017
Q2 		$2.97M Buy
60,860
+25,625
+73% +$1.32M 0.02% 827
2017
Q1 		$1.92M Buy
35,235
+114
+0.3% +$6.81K 0.01% 969
2016
Q4 		$2.11M Sell
35,121
-125
-0.4% -$6.96K 0.02% 949
2016
Q3 		$1.97M Sell
35,246
-404
-1% -$22.5K 0.01% 961
2016
Q2 		$2.08M Buy
35,650
+1,223
+4% +$74K 0.02% 921
2016
Q1 		$2.08M Buy
34,427
+630
+2% +$35.1K 0.02% 883
2015
Q4 		$2M Sell
33,797
-157
-0.5% -$9.73K 0.02% 895
2015
Q3 		$1.98M Sell
33,954
-505
-1% -$32.2K 0.01% 914
2015
Q2 		$2.59M Sell
34,459
-1,280
-4% -$96.3K 0.02% 856
2015
Q1 		$2.44M Buy
35,739
+463
+1% +$33.4K 0.02% 829
2014
Q4 		$2.71M Sell
35,276
-41
-0.1% -$3.42K 0.02% 840
2014
Q3 		$3.16M Sell
35,317
-366
-1% -$36.5K 0.02% 728
2014
Q2 		$3.9M Buy
35,683
+96
+0.3% +$10.3K 0.03% 667
2014
Q1 		$3.99M Buy
35,587
+632
+2% +$65.5K 0.03% 648
2013
Q4 		$3.84M Buy
34,955
+218
+0.6% +$24.6K 0.03% 645
2013
Q3 		$3.99M Buy
34,737
+3,523
+11% +$360K 0.03% 582
2013
Q2 		$2.82M Buy
+31,214
New +$2.73M 0.02% 712

Other funds holding INVX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
GI
GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s INVX Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Innovex International (INVX) in Q2 2024, closing a stake of 2,047 shares — an estimated $46.1K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in INVX in Q2 2013 and held it in 44 quarters. The position peaked at $3.99M in Q1 2014. 178 funds tracked by Wall St. Rank hold INVX as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Innovex International position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 2,047 Innovex International shares in Q2 2024, an estimated $46.1K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Innovex International in Q2 2013 and held it in 44 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Innovex International position peaked at $3.99M in Q1 2014.
  • 178 funds tracked by Wall St. Rank held Innovex International as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.